Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $6,939,885 | $7,311,982 | – | $7,592,632 |
| - Cash | $0 | $577,752 | – | $817,966 |
| + Debt | $0 | $46,992 | – | $50,648 |
| Enterprise Value | $6,939,885 | $6,781,222 | – | $6,825,314 |
| Revenue | $1,349,130 | – | $1,273,721 | $1,299,744 |
| % Growth | – | – | -2% | – |
| Gross Profit | $1,188,998 | – | $1,133,225 | $1,147,178 |
| % Margin | 88.1% | – | 89% | 88.3% |
| EBITDA | $378,563 | – | $399,806 | $345,567 |
| % Margin | 28.1% | – | 31.4% | 26.6% |
| Net Income | $255,018 | – | $261,825 | $200,656 |
| % Margin | 18.9% | – | 20.6% | 15.4% |
| EPS Diluted | 2.62 | – | 2.69 | 1.96 |
| % Growth | – | – | 37.2% | – |
| Operating Cash Flow | $472,198 | – | $327,252 | $367,081 |
| Capital Expenditures | -$41,941 | – | -$30,007 | -$30,339 |
| Free Cash Flow | $430,257 | – | $297,245 | $336,742 |